Personalized Evaluation of Susptected Myocardial Ischemia
Launched by GØDSTRUP HOSPITAL · Nov 24, 2024
Trial Information
Current as of June 24, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Ischemic heart disease poses a significant burden on society and affects many Danes annually. With more than 300,000 citizens in Denmark living with cardiovascular disease, and more than 17,500 cardiovascular deaths annually, the need for effective diagnosis and treatment is crucial. Cardiac Computed Tomography Angiography (CCTA) has become an important tool in diagnosing arteriosclerotic obstructive coronary artery disease (CAD) in patients with typical or atypical chest pain, but the increasing use of this method requires a more efficient selection of patients before initial testing. Earl...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with de novo chest pain referred on suspicion of stable ischemic CAD
- • Patients capable of providing written informed consent
- Exclusion Criteria:
- • Age \<30 years or \>75 years
- • Known ischemic heart disease, including previous PCI (with or without stent) and bypass surgery
- • Unstable angina pectoris at initial consultation
- • Severe COPD or asthma
- • Severe valvular disease
- * Absolute or relative contraindications for Cardiac CT:
- • allergy to iomeron
- • pregnant women, including women who are potentially pregnant or lactating
- • reduced kidney function with an estimated glomerular filtration rate \<40 ml/min
- • LVEF \<45%
About Gødstrup Hospital
Gødstrup Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. As a prominent sponsor, the hospital focuses on a wide range of therapeutic areas, fostering collaboration among multidisciplinary teams to ensure rigorous study design and ethical standards. Committed to enhancing the quality of care, Gødstrup Hospital integrates cutting-edge technology and evidence-based practices in its research initiatives, aiming to translate scientific discoveries into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Herning, , Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported